Dr. Rahul Singh

• TRAINED AT: LRS Institute of Tuberculosis and Respiratory Diseases (LRSITBRD)
• PUBLICATIONS: Singh R, Bhatt ML, Kumar R, Srivastava K, Grover RK, Shukla P, Raturi VP, Roopali, Gaur J, Saha M, Kishan D. A prospective randomized comparison of concurrent chemoradiation with neoadjuvant and adjuvant chemotherapy with concurrent chemoradiation alone for locally advanced carcinoma cervix. Indian Journal of Medical andPaediatric Oncology 2019;40:353-7
  
  

  • Raturi VP, Singh R. Multiple Inherited Schwannomas, Meningiomas and Ependymomas Syndrome in an Adult Patient. Indian Journal of Medical and Paediatric Oncology 10.4103/ijmpo.ijmpo_141_18

  
  

  • Gupta S, Singh R, Pranay K, Malhotra KP. Secretory Breast Carcinoma in Adult Female: A Case Report and Review of The Literature.International Journal of Scientific Research 10.36106/IJSR

  
  

  • Raturi VP, Kumar R, Bhatt ML, Singh R, Parmar D, Gaur J, Kishan D, Saha M, Roopali, Pranay K, Senthamizh P, Katiyar T. To Investigate The Affiliation Of XRCC-1 Gene Arg194Trp Polymorphism In Alcohol And Tobacco Substance Users And Loco-regionally Progressed Laryngeal Squamous Cell Carcinoma. Journal of Oral Biology and Craniofacial Research 10.1016/j.jobcr.2018.10.002

  
  

  • Roopali, Singh S, Gupta R, Bhatt ML, Jain M, Saha M, Raturi VP, Gaur J, Kishan D, Singh R. A Prospective Study Comparing Oxaliplatin and 5FU with Gemcitabine and Cisplatin in Advanced Stage Carcinoma Gall Bladder. Journal of Medical Science and Clinical Research10.18535/jmscr/v4i5.04
• REGISTRATION: 33032
• EDUCATION:
  MBBS
  MD Radiation Oncology
  DNB Radiation Oncology
  FRCR Clinical Oncology (I)